Dermira has announced that the FDA has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older. Primary axillary hyperhidrosis, also commonly known as excessive underarm sweating, is a chronic medical skin condition that results in sweating beyond what is needed for normal body temperature regulation.
Panasonic PhotoMOS® Photovoltaic MOSFET High-Power Drivers
Adam-Tech Wire-to-Board Solutions